Publicación:
Clinical Practice Guidelines: Diagnostic and Treatment of Multiple Sclerosis in Adults; [Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Esclerosis Múltiple en Adultos]

dc.contributor.authorVizcarra, Darwin R.
dc.contributor.authorCruz, Ana G.
dc.contributor.authorRojas, Edgar
dc.contributor.authorMori, Nicanor
dc.contributor.authorCaparó, César
dc.contributor.authorCastañeda, Carlos C.
dc.contributor.authorCastro, Sheila
dc.contributor.authorGavidia, Jorge M.
dc.contributor.authorGonzález, Oscar
dc.contributor.authorHuertas, Marco
dc.contributor.authorMeza, María
dc.contributor.authorMontalván, Víctor
dc.contributor.authorRivara, Alda
dc.contributor.authorAdrianzén, Fiorella
dc.contributor.authorDuque, Kevin
dc.contributor.authorServán, Sebastián A.
dc.contributor.authorVillafuerte, Brian J.
dc.contributor.authorVizcarra, Joaquín A.
dc.contributor.authorZamudio, Rodrigo
dc.contributor.authorNeira, Elsa R.
dc.contributor.authorCarrá, Adriana
dc.contributor.authorFernández, Oscar
dc.contributor.authorRivera, Víctor
dc.date.accessioned2026-05-14T14:28:48Z
dc.date.issued2019
dc.description.abstractMultiple Sclerosis (MS) is a chronic disease of the central nervous system, for which there is still no definitive cure; but there is a diverse variety of therapies with the objective of modifying the course of the disease, which promotes the constant inclusion of new therapeutic strategies. Objective: The Peruvian Society of Neurology, as requested by the Peruvian Health Ministry, convened a committee of experts with the purpose of elaborating a clinical practice guideline for the diagnosis and treatment of MS. Method: Clinical practice guidelines were searched and evaluated according to the AGREE II methodology, choosing the Catalan Clinical Practice Guide as a model. The clinical questions not related to treatment were solved through a systematic review. The clinical treatment questions were assessed under the PICO format and were solved with a meta-analysis of clinical trials available until August 2017, considering the therapies approved by DIGEMID until January 2017. The final recommendations were elaborated using the modified Delphi method with a consensus of at least 80% of the members of its committee. Finally, an external revision of the manuscript was made by international experts in MS. Results: Eighteen clinical questions and twenty-one recommendations for management were developed, including therapeutic algorithms. © 2019 Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado. All rights reserved.en_US
dc.identifier.doihttps://doi.org/10.20453/rnp.v82i4.3646
dc.identifier.scopus2-s2.0-85118650258
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19722
dc.language.isospa
dc.publisherUniversidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado
dc.relation.ispartofurn:issn:0034-8597
dc.relation.ispartofseriesRevista de Neuro-Psiquiatria
dc.relation.issn0034-8597
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectMultiple sclerosisen_US
dc.subjectPeruen_US
dc.subjectpractice guidelineen_US
dc.titleClinical Practice Guidelines: Diagnostic and Treatment of Multiple Sclerosis in Adults; [Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Esclerosis Múltiple en Adultos]en_US
dc.typehttps://purl.org/coar/resource_type/c_dcae04bc
dc.type.localRevisión
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos